{"id":"W2915181639","doi":"10.1093/eurheartj/ehw069","title":"Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2","year":2016,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Cilag; Janssen Pharmaceuticals; St. Jude Medical; AstraZeneca; Allergan; National Institutes of Health; H. Lundbeck A/S; Servier; Astellas Pharma; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; Fondation Leducq; British Heart Foundation; European Society of Cardiology; Boston Scientific Corporation; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alere; Bayer HealthCare; European Commission; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Thrombolysis; Internal medicine; Oral anticoagulant; Intensive care medicine; Anticoagulant; Clinical trial; Vitamin k; Cardiology; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238855,0.000738367,0.002012802,0.002546049,0.0002698545,0.001058052,0.0007227241,0.001386279,0.004586726],"category_scores_gemma":[0.004043608,0.0003148015,0.00187868,0.002380053,0.0003746877,0.0011561,0.000552684,0.0009372986,0.0006177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007390135,"about_ca_system_score_gemma":0.00172527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001838426,"about_ca_topic_score_gemma":0.003524129,"domain_scores_codex":[0.9990886,0.0003055873,0.000290423,0.00009699024,0.0001801715,0.00003825471],"domain_scores_gemma":[0.9984414,0.001112232,0.0002724522,0.00002245416,0.000128419,0.00002308771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000153099,0.0000741585,0.0006224796,0.2140273,0.001068218,0.000137762,0.0001382721,0.0003034483,0.0005100559,0.001814844,0.01249229,0.768658],"study_design_scores_gemma":[0.0002124344,0.0003390906,0.008464182,0.2714617,0.006861695,0.003827077,0.0003141284,0.0003526862,0.0007675794,0.003194305,0.7041385,0.00006659848],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00016706,0.9989157,0.0000727775,0.0002786196,0.00007865742,0.00002008916,0.00002861155,0.000001995564,0.0004364958],"genre_scores_gemma":[0.001485513,0.997603,0.0002833317,0.0002743192,0.00009032553,0.00003039631,0.00004134441,0.000001097952,0.0001906832],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004586726,"threshold_uncertainty_score":0.01534414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1581573846459282,"score_gpt":0.3960271141982049,"score_spread":0.2378697295522767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}